Development of an In Vivo Method to Estimate Effective Drug Doses and Quantify Fatty Acid Amide Hydrolase in Rodent Brain using Positron Emission Tomography Tracer N-(3,4-dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[11C]methylphenyl)thiazol-2-yl]-1-carboxamide ([11C]DFMC)

MLA

Yamasaki, Tomoteru, et al. “Development of an In Vivo Method to Estimate Effective Drug Doses and Quantify Fatty Acid Amide Hydrolase in Rodent Brain Using Positron Emission Tomography Tracer N-(3,4-Dimethylisoxazol-5-Yl)Piperazine-4-[4-(2-Fluoro-4-[11C]Methylphenyl)Thiazol-2-Yl]-1-Carboxamide ([11C]DFMC).” The Journal of Pharmacology and Experimental Therapeutics, vol. 373, no. 3, Apr. 2020, pp. 353–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.jairo.........4b12cde9cb81995215de12c41c3a46d9&authtype=sso&custid=ns315887.

APA

Yamasaki, T., Ohya, T., Mori, W., Zhang, Y., Wakizaka, H., Nengaki, N., Fujinaga, M., Kikuchi, T., Ming-Rong, Z., Tomoteru, Y., Tomoyuki, O., Wakana, M., Hidekatsu, W., Nobuki, N., Masayuki, F., Tatsuya, K., & Zhang, M.-R. (2020). Development of an In Vivo Method to Estimate Effective Drug Doses and Quantify Fatty Acid Amide Hydrolase in Rodent Brain using Positron Emission Tomography Tracer N-(3,4-dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[11C]methylphenyl)thiazol-2-yl]-1-carboxamide ([11C]DFMC). The Journal of Pharmacology and Experimental Therapeutics, 373(3), 353–360.

Chicago

Yamasaki, Tomoteru, Tomoyuki Ohya, Wakana Mori, Yiding Zhang, Hidekatsu Wakizaka, Nobuki Nengaki, Masayuki Fujinaga, et al. 2020. “Development of an In Vivo Method to Estimate Effective Drug Doses and Quantify Fatty Acid Amide Hydrolase in Rodent Brain Using Positron Emission Tomography Tracer N-(3,4-Dimethylisoxazol-5-Yl)Piperazine-4-[4-(2-Fluoro-4-[11C]Methylphenyl)Thiazol-2-Yl]-1-Carboxamide ([11C]DFMC).” The Journal of Pharmacology and Experimental Therapeutics 373 (3): 353–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.jairo.........4b12cde9cb81995215de12c41c3a46d9&authtype=sso&custid=ns315887.